Huntington disease alters the actionable information in plasma extracellular vesicles

Andreas Neueder; Philipp Nitzschner; Ronja Wagner; Julia Hummel; Franziska Hoschek; Maximilian Wagner; Alshaimaa Abdelmoez; Björn von Einem; G. Bernhard Landwehrmeyer; Sarah J. Tabrizi; Michael Orth

doi:10.1002/ctm2.1525

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1525 DOI: 10.1002/ctm2.1525

LETTER TO THE JOURNAL

Huntington disease alters the actionable information in plasma extracellular vesicles

Author information +

History +

PDF

Cite this article

Download citation ▾

Andreas Neueder, Philipp Nitzschner, Ronja Wagner, Julia Hummel, Franziska Hoschek, Maximilian Wagner, Alshaimaa Abdelmoez, Björn von Einem, G. Bernhard Landwehrmeyer, Sarah J. Tabrizi, Michael Orth. Huntington disease alters the actionable information in plasma extracellular vesicles. Clinical and Translational Medicine, 2024, 14(1): e1525 DOI:10.1002/ctm2.1525

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington's disease. Lancet Neurol. 2015;14(11):1135-1142.

[2]	Neueder A, Kojer K, Hering T, et al. Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues. Genome Biol. 2022;23(1):189.

[3]	Liu YJ, Wang C. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Commun Signal. 2023;21(1):77.

[4]	Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracellular Vesicles. 2018;7(1):1535750.

[5]	Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90-W97.

[6]	Sanchez II, Nguyen TB, England WE, et al. Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. J Clin Invest. 2021;131(12):e140723.

[7]	Pogoda A, Chmielewska N, Maciejak P, Szyndler J. Transcriptional dysregulation in Huntington's disease: the role in pathogenesis and potency for pharmacological targeting. Curr Med Chem. 2021;28(14):2783-2806.

[8]	Anand S, Samuel M, Mathivanan S. Exomeres: a new member of extracellular vesicles family. Subcell Biochem. 2021;97:89-97.

[9]	You Y, Zhang Z, Sultana N, et al. ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids. Sci Adv. 2023;9(37):eadi3647.

[10]	Hong EP, MacDonald ME, Wheeler VC, et al. Huntington's disease pathogenesis: two sequential components. J Huntington's Disease. 2021;10(1):35-51.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.